FDA orders stronger Invokana warning labels.

The risks are real.

Two years after hitting the market, the FDA issued its first Invokana warning after receiving reports of hospitalizations due ketoacidosis, a life-threatening condition. Since then, numerous other warnings have been issued, raising serious concerns about the safety of this drug.